Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.

A part of the tumor sample collected during the surgery or the biopsy performed as part of routine patient care will be used for the research.

38 mL of blood will be taken for the study.